Compass Therapeutics to Participate in Upcoming December Investor Events

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of December.

Details are as follows:

Piper Sandler 37th Annual Healthcare Conference
Location: New York, NY
Date: Tuesday, December 2, 2025
Time: 8:00 AM ET
Webcast Link: https://event.webcasts.com/starthere.jsp?ei=1744426&tp_key=c56d01f519

8th Annual Evercore Healthcare Conference
Location: Coral Gables, FL
Date: Thursday, December 4, 2025
Time: 10:00 AM ET
Webcast Link: https://wsw.com/webcast/evercore52/cmpx/2381104

Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.

Compass’ management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.

About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These pathways include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The Company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.

Investor Contact
ir@compasstherapeutics.com 

Media Contact
Anna Gifford, Chief of Staff
media@compasstherapeutics.com 
617-500-8099

Staff

Recent Posts

A True Empowerer – AGFA HealthCare Radiates Imaging Innovation at ECR 2026

In Vienna, Enterprise Imaging offers the "Clinician-First" approach to keeping radiologists in their flow, spotlighting…

3 hours ago

EDETEK Launches “Ensemble” AI Managed Services to Simplify Adoption of AI and Accelerate Clinical Development

Orchestrated AI delivered as a service for measurable impactPRINCETON, N.J., Jan. 14, 2026 /PRNewswire/ -- EDETEK…

12 hours ago

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 14,…

12 hours ago

Amsive Announces Amsive Health, Formalizing Its Healthcare Marketing Practice to Drive Accelerated Growth for Health Plans, Health Systems, and Providers

Built on decades of healthcare experience, trusted by the nation's leading brands, and powered by…

12 hours ago

Therap Services Sponsored the Arc and NASDDDS in 2025, Supporting Innovation in Human Services

TORRINGTON, Conn., Jan. 14, 2026 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

12 hours ago

Event Modules’ MobileOp4 Triage Unit Selected by AMR as Primary Medical Operations Platform for the 2026 Fiesta Bowl & College Playoff Football Semifinal

NASHVILLE, Tenn., Jan. 14, 2026 /PRNewswire/ -- Event Modules, the rental and deployment arm supporting…

12 hours ago